Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Collins Helen Louise

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ELVNEnliven Therapeutics, Inc.Collins Helen LouiseCHIEF MEDICAL OFFICERApr 11, 2024Sale$13.7840,000551,07820,000Apr 15, 2024, 07:02 PM
FPRXFIVE PRIME THERAPEUTICS, INC.Collins Helen LouiseEVP and Chief Medical OfficerFeb 26, 2021Option Exercise$22.231,15825,74277,632Mar 02, 2021, 12:08 PM
FPRXFIVE PRIME THERAPEUTICS, INC.Collins Helen LouiseEVP and Chief Medical OfficerFeb 24, 2021Option Exercise$25.715,091130,89080,443Feb 26, 2021, 02:36 PM
FPRXFIVE PRIME THERAPEUTICS, INC.Collins Helen LouiseEVP and Chief Medical OfficerFeb 25, 2021Option Exercise$23.081,65338,15178,790Feb 26, 2021, 02:36 PM
FPRXFIVE PRIME THERAPEUTICS, INC.Collins Helen LouiseEVP and Chief Medical OfficerDec 11, 2020Option Exercise$16.1411,583186,95085,534Dec 15, 2020, 12:00 PM
FPRXFIVE PRIME THERAPEUTICS, INC.Collins Helen LouiseEVP and Chief Medical OfficerNov 11, 2020Option Exercise$18.0011,039198,70275,117Nov 13, 2020, 12:25 PM
FPRXFIVE PRIME THERAPEUTICS, INC.Collins Helen LouiseEVP and Chief Medical OfficerAug 20, 2020Option Exercise$4.698273,87964,156Aug 24, 2020, 01:46 PM
FPRXFIVE PRIME THERAPEUTICS, INC.Collins Helen LouiseEVP and Chief Medical OfficerMar 20, 2020Option Exercise$2.308271,90264,983Mar 23, 2020, 12:11 PM
FPRXFIVE PRIME THERAPEUTICS, INC.Collins Helen LouiseEVP and Chief Medical OfficerFeb 25, 2020Option Exercise$4.871,8629,06867,091Feb 26, 2020, 08:22 PM
FPRXFIVE PRIME THERAPEUTICS, INC.Collins Helen LouiseEVP and Chief Medical OfficerFeb 26, 2020Option Exercise$4.831,2816,18765,810Feb 26, 2020, 08:22 PM
FPRXFIVE PRIME THERAPEUTICS, INC.Collins Helen LouiseEVP and Chief Medical OfficerFeb 05, 2020Option Exercise$5.135,34527,42038,953Feb 06, 2020, 06:51 PM
FPRXFIVE PRIME THERAPEUTICS, INC.Collins Helen LouiseEVP and Chief Medical OfficerSep 01, 2019Option Exercise$5.434962,69344,298Sep 04, 2019, 01:12 PM
FPRXFIVE PRIME THERAPEUTICS INCCollins Helen LouiseSVP and Chief Medical OfficerFeb 26, 2019Option Exercise$11.951,17714,06539,794Feb 27, 2019, 07:58 PM
FPRXFIVE PRIME THERAPEUTICS INCCollins Helen LouiseSVP and Chief Medical OfficerFeb 05, 2019Option Exercise$11.433,19636,53030,971Feb 07, 2019, 05:21 PM
FPRXFIVE PRIME THERAPEUTICS INCCollins Helen LouiseSVP and Chief Medical OfficerSep 28, 2018Option Exercise$13.921,90626,53234,167Oct 02, 2018, 06:43 PM
FPRXFIVE PRIME THERAPEUTICS INCCollins Helen LouiseSVP and Chief Medical OfficerSep 01, 2018Option Exercise$14.004966,94432,229Sep 05, 2018, 11:22 AM
FPRXFIVE PRIME THERAPEUTICS INCCollins Helen LouiseSVP and Chief Medical OfficerJun 23, 2018Option Exercise$17.381,24021,55132,725Jun 26, 2018, 08:16 PM
FPRXFIVE PRIME THERAPEUTICS INCCollins Helen LouiseSVP and Chief Medical OfficerMar 20, 2018Option Exercise$16.2682713,44733,965Mar 22, 2018, 02:50 PM
FPRXFIVE PRIME THERAPEUTICS INCCollins Helen LouiseSVP and Chief Medical OfficerJun 23, 2017Option Exercise$31.2494029,36627,792Feb 28, 2018, 07:18 PM
FPRXFIVE PRIME THERAPEUTICS INCCollins Helen LouiseSVP and Chief Medical OfficerFeb 05, 2018Option Exercise$18.421,04819,30423,732Feb 07, 2018, 02:05 PM
FPRXFIVE PRIME THERAPEUTICS INCCollins Helen LouiseSVP and Chief Medical OfficerSep 01, 2017Option Exercise$34.3437612,91224,780Sep 06, 2017, 07:11 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe